Respiratory Diagnostics - Global Market Outlook (2020 -2028)
According to Stratistics MRC, the Global Respiratory Diagnostics Market is accounted for $6.94 billion in 2020 and is expected to reach $14.14 billion by 2028 growing at a CAGR of 9.3% during the forecast period. The rising prevalence of respiratory diseases and technological advancements are the major factors propelling market growth. However, reimbursement concerns are hampering market growth.
Respiratory diagnostics have a principal part in the therapeutic innovation area. It involves the clinical assessment of some kinds of respiratory conditions such as bronchitis, asthma, COPD, pulmonary fibrosis among others by using various kinds of mechanical, imaging, and molecular diagnostics tests.
Based on the test type, the traditional diagnostic tests segment is estimated to have a lucrative growth due to it is widely used by developing countries and the fast working time of these tests allows patients to get effective results in a shorter period which further improves treatment procedures.
By geography, North America is going to have a lucrative growth during the forecast period due to the increasing prevalence of respiratory diseases and the growing anti-aging population. The U.S. dominates North America's respiratory diagnostics market due to its advanced healthcare system and strong distribution channels.
Some of the key players profiled in the Respiratory Diagnostics Market include Abbott Diagnostics Inc., Becton, Dickinson and Company, CAREstream Medical Ltd., Fisher & Paykel Healthcare, Inc., GE Healthcare Limited, Koninklijke Philips N.V, Medtronic, Inc., MGC Diagnostics Corporation, ResMed Inc., Thermo Fisher Scientific Inc., 3M, Philips Healthcare, Biomérieux, COSMED, Bio-Rad Laboratories Inc., SDI Diagnostics, Seegene Inc., and Alere Inc.
Test Types Covered:
• Imaging Tests
• Mechanical Tests
• Molecular Diagnostic Tests
• Traditional Diagnostic Tests
Product and Services Covered:
• Assays and Kits/Reagents
• Instruments and Devices
• Services and Software
• Chronic Obstructive Pulmonary Disease (COPD)
• Lung Cancer
• Other Diseases
Distribution Channels Covered:
• Retail Sales
• Direct Tender
End Users Covered:
• Hospital/Clinical Laboratories
• Physician Offices
• Reference Laboratories
• Other End Users
• North America
o Rest of Europe
• Asia Pacific
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2019, 2020, 2021, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Select License Type
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.